Yahoo
NasdaqGS - Nasdaq Real Time Price USD

ImmunityBio, Inc. (IBRX)

8.81 +0.18 (+2.09%)
At close: October 28 at 4:00:00 PM EDT
8.82 +0.01 (+0.11%)
Pre-Market: 7:10:29 AM EDT
Trade IBRX on Coinbase

News headlines

Updated 2m ago
Powered by Yahoo Scout

ImmunityBio’s FDA label expansion for ANKTIVA broadened treatment eligibility in bladder cancer. Attention now shifts to November 2026 results from a 366-patient registrational trialand a potential supplemental filing seeking earlier use. The latest regular-session move was +2.09% on October 29, 2026.

Mobilize your Website
View Site in Mobile | Classic
Share by: